Ledger.Open graph →
SEC Form D · filed August 12, 2020

Amytrx Therapeutics, Inc

Offering
$12.0M
Sold
$3.6M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NASHVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Thomas Andrews · NASHVILLE, TNDirectorLarry Greer · NASHVILLE, TNDirectorMatthew Gonda · NASHVILLE, TNExec · DirectorDaniel Pirtle · NASHVILLE, TNDirectorDaniel Canale · NASHVILLE, TNDirectorDennis Carlo · NASHVILLE, TNDirectorDaniel Pirtle · NASHVILLE, TNDirectorThomas Andrews · NASHVILLE, TNDirectorDaniel Canale · NASHVILLE, TNDirectorDennis Carlo · NASHVILLE, TNDirectorLarry Greer · NASHVILLE, TNDirectorMatthew Gonda · NASHVILLE, TNExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗